HIGHLIGHTS
- who: Alessio Rizzo and colleagues from the Department of Nuclear Medicine, Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy University of Turin, Turin, Italy have published the article: The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review, in the Journal: Cancers 2023, 355 of 24/Oct/2022
SUMMARY
Original papers reporting data about the use of PSMA-targeted PET in different clinical settings (characterization of ccRCC lesions, staging and restaging of ccRCC patients) were eligible for inclusion in this systematic review. Letters, comments, editorials . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.